This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Glaucoma Treatment Market

Glaucoma Treatment Market By Disease Type (Open Angle, Angle Closure, Others), Drug Class (Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) & Region - Forecast 2022 - 2032

Market Insights on Glaucoma Treatment covering sales outlook, demand forecast & up-to-date key trends

Glaucoma Treatment Market Outlook (2022-2032)

[331 Pages Report] The global glaucoma treatment market is expected to reach US$ 7.78 Bn in 2032, with a steady rate of 3.2% during the forecast period.

“Innovation of new technology with new pharmacological discoveries are expected to fuel the growth of the glaucoma treatment market.”

The rising frequency of glaucoma illnesses and the growing demand for sophisticated therapeutic methods are the primary reasons that led to the growth of the market. The glaucoma treatment market is expanding due to increased awareness of glaucoma due to government and pharmaceutical company promotions.

Attributes

Details

Glaucoma Treatment Market Size (2027)

US$ 11.05 Bn

Glaucoma Treatment Market Size CAGR (2022-2032)

3.2%

Glaucoma Treatment Market Size Attraction

Growing infrastructure and demand for renewable energy to offer impetus.

How COVID-19 affected the Glaucoma Treatment Market?

COVID-19 is a global public health disaster that has affected almost every company, and its long-term consequences are expected to have an influence on industry growth over the forecast period. Due to the adoption of preventive lockdown in various economies, the COVID-19 pandemic had a modest negative influence on glaucoma treatment market sales. 

Due to a lack of healthcare infrastructure, COVID-19 patients will be given priority, and all resources will be mobilized. In addition, several ophthalmology departments were transformed into COVID-19 wards, limiting glaucoma patient follow-up. 

Furthermore, lower demand for the glaucoma treatment market has occurred from fewer patient visits to clinical settings due to concern of infection among elderly persons. During the pandemic, however, the use of telemedicine platforms aided patients in receiving treatment on time, propelling the broader business forward.

Consumer demand has reduced as a result of the outbreak's negative impact on most people's general economic status since people are now more keen on cutting non-essential expenses from their varied budgets.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Driving Factors of the Glaucoma Treatment Market?

"Market is expanding as a result of technological advancements, increased awareness of glaucoma, and new drug developments."

Glaucoma incidences are rising, which is propelling the global Glaucoma Treatment Market forward. Glaucoma is a painless eye illness that does not cause any symptoms until it causes substantial vision loss; hence the number of glaucoma patients is growing by the day.

Furthermore, increasing awareness of glaucoma due to government and pharmaceutical company initiatives is propelling the glaucoma treatment market forward. As eye drops are the major control tool for glaucoma, and various pharmaceutical and biotechnological companies are investing in new product development for glaucoma, technical innovation in treatment is another driver for the market growth.

One of the primary factors driving the glaucoma treatment market outlook is continuous technological improvements in the ophthalmology industry. The industry's development potential will be fueled by the rising demand for improved surgical treatments.

Furthermore, medical imaging, selective laser trabeculoplasty (SLT), optical coherence tomography (OCT), visual fields, micro-invasive glaucoma surgery (MIGS), and progression analysis software will increase patient preference. Additionally, the market size will expand if laser therapies are combined with medications to treat glaucoma as first-line therapy.

What are the Emerging Trends in the Glaucoma Treatment Market?

Beta-blockers, alpha-adrenergic agonists, carbonic anhydrase inhibitors, and prostaglandin analogs are some drugs used to treat glaucoma, while a combination of medications is now commonly used. According to the World Health Organization, glaucoma affects more than 60 million people worldwide in 2019. 

On the other hand, the Glaucoma Treatment Market views no discomfort and no symptoms other than visible vision loss to be a challenge. According to the Glaucoma Research Foundation, more than 120,000 people in the United States are blind due to glaucoma. As a result of the increased number of cases of glaucoma, the market is predicted to rise rapidly over the forecast period.

Comparative View of Adjacent Glaucoma Treatment Market

Glaucoma Treatment Market:

Attributes

Glaucoma Treatment Market

CAGR (2022 - 2032)

3.2%

Market Value (2026)

US$ 11 Bn

Growth Factor

Innovation in new technologies to offer impetus to the market.

Opportunity

Investments in prostaglandin analogs to create opportunities.

Key Trends

Ease of use of eye drops to remain a dominant market trend.

Glaucoma Therapeutics Market:

Attributes

Glaucoma Therapeutics Market

CAGR (2022 - 2032)

6.7%

Market Value (2026)

US$ 10 Bn

Growth Factor

Rising research towards the development of prostaglandin analogs to boost adoption.

Opportunity

Robust healthcare infrastructure in emerging countries to sustain demand.

Key Trends

Development of effective therapeutics with ease of use to drive the market growth.

Glaucoma Surgery Devices Market:

Attributes

Glaucoma Surgery Devices Market

CAGR (2022 - 2032)

25%

Market Value (2026)

US$ 60 Bn

Growth Factor

Rising awareness about the condition to offer growth prospects.

Opportunity

Demand for minimally invasive surgeries to offer opportunities.

Key Trends

Intense focus on advanced technology for product development to remain a key trend.

Glaucoma is the second leading cause of blindness worldwide. This is usually caused by increased intraocular tension. Lowering intraocular tension is the main glaucoma treatment goal. This is accomplished by either decreasing aqueous humor secretion or boosting drainage. 

Open-angle (wide angle) glaucoma, chronic glaucoma, angle-closure (narrow-angle) glaucoma, and acute congestive glaucoma are all types of glaucoma. Although glaucoma medications help alleviate symptoms, there is no cure for the disease.

Glaucoma is a progressive optic neuropathy illness characterized by degeneration of the retinal nerve fiber layers and retinal ganglion cells, resulting in alterations in the optical nerve head. High intraocular pressure (IOP) is a key risk factor, as it can damage the optic nerve, which can lead to irreversible visual field abnormalities, visual impairment, and blindness.

Glaucoma can cause permanent blindness around the globe. Medications for the eyes include eye drops to improve fluid outflow or decrease fluid production. In the event of angle-closure glaucoma, a laser is occasionally used to enhance drainage (in the angle) or make a hole in the iris or colored area of the eye. 

Filtering surgery and tube-shunt surgery are two eye surgical methods that can construct an alternate fluid drainage system in the eye. Reduced eye pressure is used to treat glaucoma. Depending on your situation, prescription eye drops, oral medicines, laser treatment, surgery, or a combination of these may be offered.

Glaucoma is commonly treated with prescription eye drops. These can help lower eye pressure by altering how fluid drains from your eye or reducing the amount produced.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Segment has the Highest Market Potential?

In 2021, the open-angle glaucoma segment was worth more than USD 4.5 billion. The high prevalence of open-angle glaucoma around the world is responsible for the segment's rise. Furthermore, the increasing use of hypotensive medications to lower intraocular pressure leads to segmental enlargement.

Prostaglandin analogs are widely used to lower intraocular pressure. They have various advantages, including once-daily dosage efficacy and a faster recovery rate in glaucoma treatment, which will drive market demand. Owing to the rising accessibility and affordability of ophthalmic drugs around the world, the prostaglandin analogs sector held a market share of more than 30% in 2021.

Furthermore, the rising demand for prostaglandin medicines in combination therapy is expected to significantly boost the segment's growth. Furthermore, improving patient awareness of early glaucoma therapy and an increase in the number of patients diagnosed with early glaucoma disease will raise total market statistics.

What Leads to a High Demand for the Hospital Pharmacy Segment?

In 2021, the hospital pharmacy segment was worth more than USD 3 billion. Throughout the analysis, the segment is expected to grow significantly. The significant growth is due to the widespread availability of products in various settings for various forms of glaucoma therapy. 

Patient's preference for hospital pharmacies for prescribed medications also contributes to income growth. Furthermore, reimbursement rules and insurance coverage for drug purchases made in hospital settings are expected to improve market predictions.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

What is the Geographical Outlook for the Glaucoma Treatment Market?

Over the forecast timeframe, the North American glaucoma treatment market is expected to increase at a CAGR of 3.4%. The rising prevalence of various types of glaucoma in the region would boost the demand for glaucoma therapies. 

The market will grow as more people become aware of the importance of eye care and the associated diagnoses and treatments. Furthermore, the region's significant presence of important market companies involved in new drug research and product approvals would boost regional industry growth.

Due to the increased glaucoma incidence and improved healthcare infrastructure, the United States is likely to be the largest glaucoma treatment market. According to the BrightFocus Foundation, more than 3 million Americans are affected by glaucoma, with open-angle glaucoma being the most frequent type.

Furthermore, glaucoma costs the US economy approximately USD 2.86 billion in direct costs and productivity losses each year. In addition, many organizations in the United States are raising awareness of glaucoma, which is projected to boost the market's overall growth.

How does the Competition Intensify in the Glaucoma Treatment Market?

Merck & Co., Inc.AERIE Pharmaceuticals, Inc., Cipla Inc, AbbVie, Akorn operating company LLC, Bausch & Lomb Incorporated, Inotek Pharmaceuticals, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Santen Pharmaceutical Co., Ltd. are some of the major players in the glaucoma treatment market. 

To acquire a competitive advantage over competitors in the glaucoma treatment market, these industry players use different growth methods, such as collaboration, partnership, acquisition & merger, and product introduction.

  • Teva Pharmaceuticals announced the first generic version of AZOPT (brinzolamide ophthalmic suspension) 1 percent in March 2021 in the United States to treat open-angle glaucoma and ocular hypertension. The company's product portfolio has been strengthened as a result of this.
  • Aerie Pharmaceuticals and Santen Pharmaceuticals partnered in December 2021 to develop and market Rhopressa/Rhokiinsa and Rocklatan/Roclanda for glaucoma therapy in Europe, India, China, Oceania, and parts of Latin America. Both companies' market positions in these regions will be strengthened due to this.

Key segments

By Disease Type:

  • Open Angle Glaucoma
  • Angle Closure Glaucoma
  • Other

By Drug Class:

  • Prostaglandin Analog
  • Beta Blockers
  • Adrenergic Agonist
  • Carbonic Anhydrase Inhibitors
  • Others

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Frequently Asked Questions

The glaucoma treatment market is estimated to record a 3.2% CAGR during the forecast period.

The projected value of the glaucoma treatment market is expected to be US$ 7.78 Bn by 2032.

The global glaucoma treatment market was valued at US$ 5.5 Bn in 2021.

Hospital pharmacy segment accounts for the largest revenue share.

North America is growing at the highest CAGR during the forecast period.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook 

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Fact.MR Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy 

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment 

    3.1. Risk Assessment 

        3.1.1. COVID-19 Crisis and Impact on Glaucoma Treatment Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis 

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background 

    4.1. Glaucoma Treatment Market, by Key Countries

    4.2. Glaucoma Treatment Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast 

        4.3.1. Demand in Optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario 

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Glaucoma Treatment Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Glaucoma Treatment Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors 

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking 

6. Global Glaucoma Treatment Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Glaucoma Treatment Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032, By Disease Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Disease Type, 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Type, 2022-2032

        8.3.1. Open Angle Glaucoma

        8.3.2. Angle Closure Glaucoma

        8.3.3. Others

    8.4. Market Attractiveness Analysis By Disease Type

9. Global Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032, By Drug Class

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2015-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2022-2032

        9.3.1. Prostaglandin Analogs

        9.3.2. Beta Blockers

        9.3.3. Adrenergic Agonists

        9.3.4. Carbonic Anhydrase Inhibitors

        9.3.5. Others

    9.4. Market Attractiveness Analysis By Drug Class

10. Global Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032, By Distribution Channel

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Disease Type, 2015-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022-2032

        10.3.1. Hospital Pharmacy

        10.3.2. Retail Pharmacy

        10.3.3. Online Pharmacy

    10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. Asia Pacific 

        11.3.5. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        12.4.1. By Country

            12.4.1.1. U.S.

            12.4.1.2. Canada

            12.4.1.3. Rest of North America

        12.4.2. By Disease Type

        12.4.3. By Distribution Channel

        12.4.4. By Drug Class

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Disease Type

        12.5.3. By Distribution Channel

        12.5.4. By Drug Class

13. Latin America Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. Brazil

            13.4.1.2. Mexico

            13.4.1.3. Rest of Latin America

        13.4.2. By Disease Type

        13.4.3. By Distribution Channel

        13.4.4. By Drug Class

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Disease Type

        13.5.3. By Distribution Channel

        13.5.4. By Drug Class

14. Europe Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. Germany

            14.4.1.2. France

            14.4.1.3. U.K.

            14.4.1.4. Italy

            14.4.1.5. Benelux

            14.4.1.6. Nordic Countries

            14.4.1.7. Rest of Europe

        14.4.2. By Disease Type

        14.4.3. By Distribution Channel

        14.4.4. By Drug Class

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Disease Type

        14.5.3. By Distribution Channel

        14.5.4. By Drug Class

15. Asia Pacific Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. China

            15.4.1.2. Japan

            15.4.1.3. South Korea

            15.4.1.4. Rest of Asia Pacific

        15.4.2. By Disease Type

        15.4.3. By Distribution Channel

        15.4.4. By Drug Class

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Disease Type

        15.5.3. By Distribution Channel

        15.5.4. By Drug Class

16. Middle East and Africa Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. GCC Countries

            16.4.1.2. South Africa

            16.4.1.3. Turkey

            16.4.1.4. Rest of Middle East and Africa

        16.4.2. By Disease Type

        16.4.3. By Distribution Channel

        16.4.4. By Drug Class

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Disease Type

        16.5.3. By Distribution Channel

        16.5.4. By Drug Class

17. Key Countries Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032

    17.1. Introduction

        17.1.1. Market Value Proportion Analysis, By Key Countries

        17.1.2. Global Vs. Country Growth Comparison

    17.2. US Glaucoma Treatment Market Analysis

        17.2.1. Value Proportion Analysis by Market Taxonomy

        17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.2.2.1. By Disease Type

            17.2.2.2. By Distribution Channel

            17.2.2.3. By Drug Class

    17.3. Canada Glaucoma Treatment Market Analysis

        17.3.1. Value Proportion Analysis by Market Taxonomy

        17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.3.2.1. By Disease Type

            17.3.2.2. By Distribution Channel

            17.3.2.3. By Drug Class

    17.4. Mexico Glaucoma Treatment Market Analysis

        17.4.1. Value Proportion Analysis by Market Taxonomy

        17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.4.2.1. By Disease Type

            17.4.2.2. By Distribution Channel

            17.4.2.3. By Drug Class

    17.5. Brazil Glaucoma Treatment Market Analysis

        17.5.1. Value Proportion Analysis by Market Taxonomy

        17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.5.2.1. By Disease Type

            17.5.2.2. By Distribution Channel

            17.5.2.3. By Drug Class

    17.6. Germany Glaucoma Treatment Market Analysis

        17.6.1. Value Proportion Analysis by Market Taxonomy

        17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.6.2.1. By Disease Type

            17.6.2.2. By Distribution Channel

            17.6.2.3. By Drug Class

    17.7. France Glaucoma Treatment Market Analysis

        17.7.1. Value Proportion Analysis by Market Taxonomy

        17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.7.2.1. By Disease Type

            17.7.2.2. By Distribution Channel

            17.7.2.3. By Drug Class

    17.8. Italy Glaucoma Treatment Market Analysis

        17.8.1. Value Proportion Analysis by Market Taxonomy

        17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.8.2.1. By Disease Type

            17.8.2.2. By Distribution Channel

            17.8.2.3. By Drug Class

    17.9. BENELUX Glaucoma Treatment Market Analysis

        17.9.1. Value Proportion Analysis by Market Taxonomy

        17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.9.2.1. By Disease Type

            17.9.2.2. By Distribution Channel

            17.9.2.3. By Drug Class

    17.10. UK Glaucoma Treatment Market Analysis

        17.10.1. Value Proportion Analysis by Market Taxonomy

        17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.10.2.1. By Disease Type

            17.10.2.2. By Distribution Channel

            17.10.2.3. By Drug Class

    17.11. Nordic Countries Glaucoma Treatment Market Analysis

        17.11.1. Value Proportion Analysis by Market Taxonomy

        17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.11.2.1. By Disease Type

            17.11.2.2. By Distribution Channel

            17.11.2.3. By Drug Class

    17.12. China Glaucoma Treatment Market Analysis

        17.12.1. Value Proportion Analysis by Market Taxonomy

        17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.12.2.1. By Disease Type

            17.12.2.2. By Distribution Channel

            17.12.2.3. By Drug Class

    17.13. Japan Glaucoma Treatment Market Analysis

        17.13.1. Value Proportion Analysis by Market Taxonomy

        17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.13.2.1. By Disease Type

            17.13.2.2. By Distribution Channel

            17.13.2.3. By Drug Class

    17.14. South Korea Glaucoma Treatment Market Analysis

        17.14.1. Value Proportion Analysis by Market Taxonomy

        17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.14.2.1. By Disease Type

            17.14.2.2. By Distribution Channel

            17.14.2.3. By Drug Class

    17.15. GCC Countries Glaucoma Treatment Market Analysis

        17.15.1. Value Proportion Analysis by Market Taxonomy

        17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.15.2.1. By Disease Type

            17.15.2.2. By Distribution Channel

            17.15.2.3. By Drug Class

    17.16. South Africa Glaucoma Treatment Market Analysis

        17.16.1. Value Proportion Analysis by Market Taxonomy

        17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.16.2.1. By Disease Type

            17.16.2.2. By Distribution Channel

            17.16.2.3. By Drug Class

    17.17. Turkey Glaucoma Treatment Market Analysis

        17.17.1. Value Proportion Analysis by Market Taxonomy

        17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.17.2.1. By Disease Type

            17.17.2.2. By Distribution Channel

            17.17.2.3. By Drug Class

        17.17.3. Competition Landscape and Player Concentration in the Country

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies 

    18.2. Market Concentration

    18.3. Market Share Analysis of Top Players

    18.4. Market Presence Analysis

        18.4.1. By Regional footprint of Players

        18.4.2. Product footprint by Players

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive 

        19.3.1. AERIE Pharmaceuticals, Inc.

            19.3.1.1. Overview

            19.3.1.2. Product Portfolio

            19.3.1.3. Sales Footprint

            19.3.1.4. Strategy Overview

        19.3.2. Cipla Inc.

            19.3.2.1. Overview

            19.3.2.2. Product Portfolio

            19.3.2.3. Sales Footprint

            19.3.2.4. Strategy Overview

        19.3.3. Akorn Operating Company LLC

            19.3.3.1. Overview

            19.3.3.2. Product Portfolio

            19.3.3.3. Sales Footprint

            19.3.3.4. Strategy Overview

        19.3.4. AbbVie

            19.3.4.1. Overview

            19.3.4.2. Product Portfolio

            19.3.4.3. Sales Footprint

            19.3.4.4. Strategy Overview

        19.3.5. Bausch & Lomb Incorporated

            19.3.5.1. Overview

            19.3.5.2. Product Portfolio

            19.3.5.3. Sales Footprint

            19.3.5.4. Strategy Overview

        19.3.6. Inotek Pharmaceuticals

            19.3.6.1. Overview

            19.3.6.2. Product Portfolio

            19.3.6.3. Sales Footprint

            19.3.6.4. Strategy Overview

        19.3.7. Merck & Co., Inc.

            19.3.7.1. Overview

            19.3.7.2. Product Portfolio

            19.3.7.3. Sales Footprint

            19.3.7.4. Strategy Overview

        19.3.8. Novartis AG

            19.3.8.1. Overview

            19.3.8.2. Product Portfolio

            19.3.8.3. Sales Footprint

            19.3.8.4. Strategy Overview

        19.3.9. Pfizer Inc.

            19.3.9.1. Overview

            19.3.9.2. Product Portfolio

            19.3.9.3. Sales Footprint

            19.3.9.4. Strategy Overview

        19.3.10. Santen Pharmaceutical Co., Ltd.

            19.3.10.1. Overview

            19.3.10.2. Product Portfolio

            19.3.10.3. Sales Footprint

            19.3.10.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2015 – 2021

Table 2: Global Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2022 – 2032

Table 3: Global Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2015 – 2021

Table 4: Global Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2022 – 2032

Table 5: Global Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2015 – 2021

Table 6: Global Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2022 – 2032

Table 7: Global Glaucoma Treatment Market, By Region, 2015 – 2021

Table 8: Global Glaucoma Treatment Market, By Region, 2022 – 2032

Table 9: North America Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2015 – 2021

Table 10: North America Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2022 – 2032

Table 11: North America Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2015 – 2021

Table 12: North America Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2022 – 2032

Table 13: North America Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2015 – 2021

Table 14: North America Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2022 – 2032

Table 15: North America Glaucoma Treatment Market, By Country, 2015 – 2021

Table 16: North America Glaucoma Treatment Market, By Country, 2022 – 2032

Table 17: Latin America Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2015 – 2021

Table 18: Latin America Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2022 – 2032

Table 19: Latin America Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2015 – 2021

Table 20: Latin America Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2022 – 2032

Table 21: Latin America Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2015 – 2021

Table 22: Latin America Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2022 – 2032

Table 23: Latin America Glaucoma Treatment Market, By Country, 2015 – 2021

Table 24: Latin America Glaucoma Treatment Market, By Country, 2022 – 2032

Table 25: Europe Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2015 – 2021

Table 26: Europe Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2022 – 2032

Table 27: Europe Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2015 – 2021

Table 28: Europe Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2022 – 2032

Table 29: Europe Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2015 – 2021

Table 30: Europe Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2022 – 2032

Table 31: Europe Glaucoma Treatment Market, By Country, 2015 – 2021

Table 32: Europe Glaucoma Treatment Market, By Country, 2022 – 2032

Table 33: Asia Pacific Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2015 – 2021

Table 34: Asia Pacific Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2022 – 2032

Table 35: Asia Pacific Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2015 – 2021

Table 36: Asia Pacific Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2022 – 2032

Table 37: Asia Pacific Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2015 – 2021

Table 38: Asia Pacific Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2022 – 2032

Table 39: Asia Pacific Glaucoma Treatment Market, By Country, 2015 – 2021

Table 40: Asia Pacific Glaucoma Treatment Market, By Country, 2022 – 2032

Table 41: MEA Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2015 – 2021

Table 42: MEA Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2022 – 2032

Table 43: MEA Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2015 – 2021

Table 44: MEA Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2022 – 2032

Table 45: MEA Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2015 – 2021

Table 46: MEA Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2022 – 2032

Table 47: MEA Glaucoma Treatment Market, By Country, 2015 – 2021

Table 48: MEA Glaucoma Treatment Market, By Country, 2022 – 2032

Table 49: Global Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2015 - 2021

Table 50: Global Glaucoma Treatment Market Incremental $ Opportunity, By Distribution Channel, 2022 – 2032

Table 51: Global Glaucoma Treatment Market Incremental $ Opportunity, By Drug Class, 2015 - 2021

Table 52: Global Glaucoma Treatment Market Incremental $ Opportunity, By Region, 2022 – 2032

Table 53: North America Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2015 - 2021

Table 54: North America Glaucoma Treatment Market Incremental $ Opportunity, By Distribution Channel, 2022 – 2032

Table 55: North America Glaucoma Treatment Market Incremental $ Opportunity, By Drug Class, 2015 – 2021

Table 56: North America Glaucoma Treatment Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 57: Latin America Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2015 - 2021

Table 58: Latin America Glaucoma Treatment Market Incremental $ Opportunity, By Distribution Channel, 2022 – 2032

Table 59: Latin America Glaucoma Treatment Market Incremental $ Opportunity, By Drug Class, 2015 - 2021

Table 60: Latin America Glaucoma Treatment Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 61: Europe Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2015 - 2021

Table 62: Europe Glaucoma Treatment Market Incremental $ Opportunity, By Distribution Channel, 2022 – 2032

Table 63: Europe Glaucoma Treatment Market Incremental $ Opportunity, By Drug Class, 2015 - 2021

Table 64: Europe Glaucoma Treatment Market Incremental $ Opportunity, By Country, 2022 - 2032

Table 65: Asia Pacific Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2015 - 2021

Table 66: Asia Pacific Glaucoma Treatment Market Incremental $ Opportunity, By Distribution Channel, 2022 – 2032

Table 67: Asia Pacific Glaucoma Treatment Market Incremental $ Opportunity, By Distribution Channel, 2015 - 2021

Table 68: Asia Pacific Glaucoma Treatment Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 69: MEA Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2015 - 2021

Table 70: MEA Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2022 – 2032

Table 71: MEA Glaucoma Treatment Market Incremental $ Opportunity, By Drug Class, 2015 - 2021

Table 72: MEA Glaucoma Treatment Market Incremental $ Opportunity, By Country, 2022 - 2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Global Glaucoma Treatment Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 2: Global Glaucoma Treatment Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global Glaucoma Treatment Market Share, By Disease Type, 2022 & 2032

Figure 4: Global Glaucoma Treatment Market Y-o-Y Growth Projections, By Disease Type – 2022-2032

Figure 5: Global Glaucoma Treatment Market Attractiveness Index, By Disease Type – 2022-2032

Figure 6: Global Glaucoma Treatment Market Share, By Distribution Channel, 2022 & 2032

Figure 7: Global Glaucoma Treatment Market Y-o-Y Growth Projections, By Distribution Channel – 2022-2032

Figure 8: Global Glaucoma Treatment Market Attractiveness Index, By Distribution Channel – 2022-2032

Figure 9: Global Glaucoma Treatment Market Share, By Drug Class, 2022 & 2032

Figure 10: Global Glaucoma Treatment Market Y-o-Y Growth Projections, By Drug Class – 2022-2032

Figure 11: Global Glaucoma Treatment Market Attractiveness Index, By Drug Class – 2022-2032

Figure 12: Global Glaucoma Treatment Market Share, By Region, 2022 & 2032

Figure 13: Global Glaucoma Treatment Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 14: Global Glaucoma Treatment Market Attractiveness Index, By Region – 2022-2032

Figure 15: North America Glaucoma Treatment Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 16: North America Glaucoma Treatment Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 17: North America Glaucoma Treatment Market Share, By Disease Type, 2022 & 2032

Figure 18: North America Glaucoma Treatment Market Y-o-Y Growth Projections, By Disease Type – 2022-2032

Figure 19: North America Glaucoma Treatment Market Attractiveness Index, By Disease Type – 2022-2032

Figure 20: North America Glaucoma Treatment Market Share, By Distribution Channel, 2022 & 2032

Figure 21: North America Glaucoma Treatment Market Y-o-Y Growth Projections, By Distribution Channel – 2022-2032

Figure 22: North America Glaucoma Treatment Market Attractiveness Index, By Distribution Channel – 2022-2032

Figure 23: North America Glaucoma Treatment Market Share, By Drug Class, 2022 & 2032

Figure 24: North America Glaucoma Treatment Market Y-o-Y Growth Projections, By Drug Class – 2022-2032

Figure 25: North America Glaucoma Treatment Market Attractiveness Index, By Drug Class – 2022-2032

Figure 26: North America Glaucoma Treatment Market Share, By Country, 2022 & 2032

Figure 27: North America Glaucoma Treatment Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 28: North America Glaucoma Treatment Market Attractiveness Index, By Country – 2022-2032

Figure 29: Latin America Glaucoma Treatment Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 30: Latin America Glaucoma Treatment Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 31: Latin America Glaucoma Treatment Market Share, By Disease Type, 2022 & 2032

Figure 32: Latin America Glaucoma Treatment Market Y-o-Y Growth Projections, By Disease Type – 2022-2032

Figure 33: Latin America Glaucoma Treatment Market Attractiveness Index, By Disease Type – 2022-2032

Figure 34: Latin America Glaucoma Treatment Market Share, By Distribution Channel, 2022 & 2032

Figure 35: Latin America Glaucoma Treatment Market Y-o-Y Growth Projections, By Distribution Channel – 2022-2032

Figure 36: Latin America Glaucoma Treatment Market Attractiveness Index, By Distribution Channel – 2022-2032

Figure 37: Latin America Glaucoma Treatment Market Share, By Drug Class, 2022 & 2032

Figure 38: Latin America Glaucoma Treatment Market Y-o-Y Growth Projections, By Drug Class – 2022-2032

Figure 39: Latin America Glaucoma Treatment Market Attractiveness Index, By Drug Class – 2022-2032

Figure 40: Latin America Glaucoma Treatment Market Share, By Country, 2022 & 2032

Figure 41: Latin America Glaucoma Treatment Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 42: Latin America Glaucoma Treatment Market Attractiveness Index, By Country – 2022-2032

Figure 43: Europe Glaucoma Treatment Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 44: Europe Glaucoma Treatment Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 45: Europe Glaucoma Treatment Market Share, By Disease Type, 2022 & 2032

Figure 46: Europe Glaucoma Treatment Market Y-o-Y Growth Projections, By Disease Type – 2022-2032

Figure 47: Europe Glaucoma Treatment Market Attractiveness Index, By Disease Type – 2022-2032

Figure 48: Europe Glaucoma Treatment Market Share, By Distribution Channel, 2022 & 2032

Figure 49: Europe Glaucoma Treatment Market Y-o-Y Growth Projections, By Distribution Channel – 2022-2032

Figure 50: Europe Glaucoma Treatment Market Attractiveness Index, By Distribution Channel – 2022-2032

Figure 51: Europe Glaucoma Treatment Market Share, By Drug Class, 2022 & 2032

Figure 52: Europe Glaucoma Treatment Market Y-o-Y Growth Projections, By Drug Class – 2022-2032

Figure 53: Europe Glaucoma Treatment Market Attractiveness Index, By Drug Class – 2022-2032

Figure 54: Europe Glaucoma Treatment Market Share, By Country, 2022 & 2032

Figure 55: Europe Glaucoma Treatment Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 56: Europe Glaucoma Treatment Market Attractiveness Index, By Country – 2022-2032

Figure 57: MEA Glaucoma Treatment Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 58: MEA Glaucoma Treatment Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 59: MEA Glaucoma Treatment Market Share, By Disease Type, 2022 & 2032

Figure 60: MEA Glaucoma Treatment Market Y-o-Y Growth Projections, By Disease Type – 2022-2032

Figure 61: MEA Glaucoma Treatment Market Attractiveness Index, By Disease Type – 2022-2032

Figure 62: MEA Glaucoma Treatment Market Share, By Distribution Channel, 2022 & 2032

Figure 63: MEA Glaucoma Treatment Market Y-o-Y Growth Projections, By Distribution Channel – 2022-2032

Figure 64: MEA Glaucoma Treatment Market Attractiveness Index, By Distribution Channel – 2022-2032

Figure 65: MEA Glaucoma Treatment Market Share, By Drug Class, 2022 & 2032

Figure 66: MEA Glaucoma Treatment Market Y-o-Y Growth Projections, By Drug Class – 2022-2032

Figure 67: MEA Glaucoma Treatment Market Attractiveness Index, By Drug Class – 2022-2032

Figure 68: MEA Glaucoma Treatment Market Share, By Country, 2022 & 2032

Figure 69: MEA Glaucoma Treatment Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 70: MEA Glaucoma Treatment Market Attractiveness Index, By Country – 2022-2032

Figure 71: Asia Pacific Glaucoma Treatment Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 72: Asia Pacific Glaucoma Treatment Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 73: Asia Pacific Glaucoma Treatment Market Share, By Disease Type, 2022 & 2032

Figure 74: Asia Pacific Glaucoma Treatment Market Y-o-Y Growth Projections, By Disease Type – 2022-2032

Figure 75: Asia Pacific Glaucoma Treatment Market Attractiveness Index, By Disease Type – 2022-2032

Figure 76: Asia Pacific Glaucoma Treatment Market Share, By Distribution Channel, 2022 & 2032

Figure 77: Asia Pacific Glaucoma Treatment Market Y-o-Y Growth Projections, By Distribution Channel – 2022-2032

Figure 78: Asia Pacific Glaucoma Treatment Market Attractiveness Index, By Distribution Channel – 2022-2032

Figure 79: Asia Pacific Glaucoma Treatment Market Share, By Drug Class, 2022 & 2032

Figure 80: Asia Pacific Glaucoma Treatment Market Y-o-Y Growth Projections, By Drug Class – 2022-2032

Figure 81: Asia Pacific Glaucoma Treatment Market Attractiveness Index, By Drug Class – 2022-2032

Figure 82: Asia Pacific Glaucoma Treatment Market Share, By Country, 2022 & 2032

Figure 83: Asia Pacific Glaucoma Treatment Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 84: Asia Pacific Glaucoma Treatment Market Attractiveness Index, By Country – 2022-2032

Figure 85: US Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 86: US Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 87: US Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 88: US Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 89: Canada Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 90: Canada Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 91: Canada Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 92: Canada Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 93: Brazil Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 94: Brazil Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 95: Brazil Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 96: Brazil Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 97: Mexico Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 98: Mexico Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 99: Mexico Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 100: Mexico Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 101: Germany Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 102: Germany Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 103: Germany Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 104: Germany Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 105: U.K. Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 106: U.K. Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 107: U.K. Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 108: U.K. Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 109: France Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 110: France Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 111: France Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 112: France Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 113: Italy Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 114: Italy Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 115: Italy Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 116: Italy Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 117: BENELUX Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 118: BENELUX Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 119: BENELUX Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 120: BENELUX Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 121: Nordic Countries Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 122: Nordic Countries Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 123: Nordic Countries Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 124: Nordic Countries Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 125: China Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 126: China Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 127: China Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 128: China Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 129: Japan Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 130: Japan Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 131: Japan Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 132: Japan Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 133: South Korea Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 134: South Korea Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 135: South Korea Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 136: South Korea Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 137: GCC Countries Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 138: GCC Countries Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 139: GCC Countries Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 140: GCC Countries Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 141: South Africa Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 142: South Africa Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 143: South Africa Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 144: South Africa Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 145: Turkey Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 146: Turkey Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 147: Turkey Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 148: Turkey Glaucoma Treatment Market Share, By Drug Class, 2021

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Glaucoma Treatment Market